Immunocore Holdings plc (IMCR) Free cash flow 2021–2025
Immunocore Holdings plc (IMCR) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$15.1MFY2025 · since FY2021: -$144.5M → -$15.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$15.1M | -172.1% |
| FY2024 | $20.9M | +940.6% |
| FY2023 | -$2.5M | +95.2% |
| FY2022 | -$51.4M | +64.4% |
| FY2021 | -$144.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More IMCR financial trends
IMCR RevenueIMCR Net incomeIMCR Net marginIMCR Gross profitIMCR Gross marginIMCR Operating incomeIMCR Operating marginIMCR Operating cash flowIMCR Capital expendituresIMCR Return on equityIMCR Stock buybacksIMCR Dividends paidIMCR Total assetsIMCR Total liabilitiesIMCR Shareholders’ equityIMCR overview →